MedTrace Logo

N-3 PUFA and Rheumatoid Arthritis in Korea

NCT01618019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2012-10-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if supplementation of n-3 polyunsaturated fatty acid (PUFA) can be beneficial for the patients with rheumatoid arthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acid

5 capsules/day of either n-3 PUFA, containing 2.09 g eicosapentaenoic acid and 1.165 g docosahexaenoic acid

DIETARY_SUPPLEMENT

Placebo

5 capsules/day of placebo containing sunflower with oleic acid (DSM Nutritional products, Switzerland)

Sponsors & Collaborators

  • Hanyang University

    lead OTHER

Principal Investigators

  • Yongsoon Park, PhD · Hanyang University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01618019 on ClinicalTrials.gov